Nature Medicine | Spoonful of Medicine

Cancer vaccine approval could open floodgates (subscription)

syringe.jpgThe US Food and Drug Administration approved the first-ever vaccine to treat cancer on 29 April. After a three-year battle with the regulatory agency and three phase 3 trials, the treatment—called Provenge, by Seattle-based Dendreon—extended median survival time in men with advanced prostate cancer by more than four months. (Click here to continue reading)

Image by Zaldylmg via Flickr Creative Commons

Comments

There are currently no comments.